Welcome to our dedicated page for Nitches news (Ticker: NICH), a resource for investors and traders seeking the latest updates and insights on Nitches stock.
Nitches Inc. reports on its human performance and wellness platform, with recurring updates centered on InTheZone Labs, its wholly owned subsidiary. Company news focuses on nootropic and nutraceutical products for brain health, recovery, focus, energy and wellness, along with domestic formulation, quality controls and compliant marketing.
Updates also cover affiliate and distributor expansion through social-commerce and online channels, GovX-supported programs for service communities, subsidiary commercialization plans, and the company's audit and reporting-status initiatives.
Nitches Inc. (OTC PINK:NICH) announces the launch of its supplement brand, InTheZone Labs, on ShareASale, a major affiliate network with over 240,000 active partners worldwide. The company is currently conducting phase one testing of its supplements with former NFL players, U.S. veterans, medical professionals, and former wrestlers. The products, manufactured in an FDA-compliant facility in America, are receiving positive feedback for cognitive enhancement and stress management. The launch on ShareASale provides affiliates with marketing tools, including banners, text links, and exclusive content, positioning the company to capture a share of the $150 billion global dietary supplements market.
Nitches Inc (OTC PINK:NICH) has initiated Phase One testing of its InTheZone Focused Extreme supplement, led by a U.S. Army veteran First Sergeant. The testing targets feedback from veterans, law enforcement, and firefighters operating in high-stress environments. The supplement, containing ingredients like L-Theanine, Bacopa Monnieri, and Alpha-GPC, aims to enhance clarity and mental resilience. Early feedback from veteran testers has been positive. The company announced that its entire InTheZone product line will be available on Amazon next week, and is pursuing additional affiliate and distribution partnerships.
Nitches (OTC:NICH) announces expansion of InTheZone Labs through new distribution and affiliate opportunities. The company launches an affiliate program offering 20% commission on sales and initiates Phase One Testing with key influencers including medical professionals, former NFL players, and veterans. The company's product line features three bioceutical solutions: InTheZone Focused Extreme, InTheZone Passion, and InTheZone Youth, incorporating ingredients like Alpha-GPC, Lion's Mane Mushroom, and Omega-3 DHA. Early customer feedback reports improvements in focus and mental clarity. Products are currently available for purchase at InTheZoneLabs.com.
Nitches Inc (OTC PINK:NICH) has launched InTheZone Focused Extreme, a new cognitive enhancement supplement under its InTheZone Labs product line. The supplement features key ingredients including Alpha-GPC, Lion's Mane Mushroom, Caffeine Anhydrous, L-Theanine, Bacopa Monnieri (300mg), and Rhodiola Rosea (200mg). The product is manufactured in the USA in FDA-compliant, GMP-certified facilities with ISO 9001 and USP certifications. This launch positions Nitches to capitalize on the growing nutraceutical market, which is projected to exceed $650 billion by 2027.
Nitches, Inc. (OTC PINK:NICH) announces the commencement of Phase One Testing for its InTheZone Labs division's bioceutical products. The company is developing three flagship products: InTheZone Focused Extreme for mental clarity, InTheZone Passion for men's vitality, and InTheZone Youth for cognitive development in children and young adults.
The testing phase will involve three key groups: veterans and their families, medical and chiropractic experts, and former NFL players. This comprehensive approach aims to gather critical insights and refine the products for various demographics. Nitches encourages the public to visit InTheZoneLabs.com to explore and purchase these products.
The company is positioning itself to capitalize on the projected $650 billion nutraceutical and bioceutical market by 2027, offering American-made, science-backed health solutions.
Nitches, Inc. (OTC PINK:NICH) has launched InTheZone Passion, a new supplement for men's sexual health and vitality. This product aims to address declining sperm health and virility issues faced by many men due to aging and environmental stressors. Key ingredients include:
- Tribulus Terrestris for libido and sperm count
- Maca Root for fertility and energy
- L-Citrulline for blood flow and performance
- Zinc for sperm quality
- Ashwagandha (300mg) for sperm quality and testosterone
- Fenugreek Extract (500mg) for testosterone and libido
The supplement targets the growing nutraceutical market, projected to reach $650 billion by 2027. Nitches is focusing on building partnerships with distributors and affiliates to expand its reach in the men's health sector.
Nitches, Inc. (OTC PINK:NICH) has launched InTheZone Youth, a new American-made supplement designed to enhance focus and cognitive health in adolescents and young adults. This product, part of the InTheZone Labs line, aims to address concentration, memory, and decision-making challenges in school-age children, particularly those with ADHD.
Key ingredients include Omega-3 DHA, Alpha-GPC, Lion's Mane Mushroom, Bacopa Monnieri, and Astragalus Extract, each chosen for their cognitive health benefits. The supplement is manufactured in the USA in an FDA-compliant facility, adhering to Good Manufacturing Practices (GMP).
This launch represents a strategic step for Nitches in the rapidly growing nutraceutical market, projected to exceed $650 billion by 2027. The company is actively seeking to expand its affiliate and distributor network through InTheZoneLabs.com.
Nitches, Inc. (OTC PINK:NICH) has launched InTheZone Labs, a new vertical in partnership with a leading American bioceutical and nutraceutical manufacturer. This expansion introduces a range of products designed to enhance mental focus, vitality, and cognitive development. The manufacturing partner boasts certifications including GMP, FDA-audited facility standards, NSF, and ISO-90001, ensuring product safety and quality.
The flagship products include InTheZone Focused for sustained mental performance, InTheZone Passion for boosting energy and vitality, and InTheZone Focused Youth for supporting cognitive development in younger individuals. Nitches is setting up a Phase One Study led by medical experts and former NFL athletes to validate the products' effectiveness.
The company aims to capitalize on the projected $650 billion nutraceutical and bioceutical market by 2027. Nitches is building a distribution and affiliate network, inviting professionals to join through their website at InTheZoneLabs.com.
Nitches, Inc. (OTC:NICH) announces the launch of a new website and premium bioceutical product line on Wednesday. The company has partnered with a respected American-based manufacturing facility known for high safety and quality standards. The product line focuses on mental focus, vitality, and youth cognitive development, addressing pressing health challenges. Key features include:
1. Mental Focus and Cognitive Support for professionals, students, and athletes
2. Vitality and Energy formulation for improved mood and physical well-being
3. Youth Cognitive Development support for academic and extracurricular excellence
The products are Made in the USA, adhering to Good Manufacturing Practices (GMP) and FDA guidelines. Nitches aims to set a new standard in the bioceutical industry with this launch, emphasizing American craftsmanship and quality.
Nitches, Inc. (OTC Pink:NICH) is set to launch a revolutionary science-based bioceutical product line in October 2024. The company has developed three meticulously formulated products in collaboration with top-tier scientists, doctors, and FDA-approved manufacturing facilities. These products are designed to enhance human performance and well-being for both teenagers and adults.
Key highlights of the upcoming launch include:
- Revolutionary formulations backed by robust scientific research
- Uncompromising quality with manufacturing in FDA-registered facilities under cGMP guidelines
- Global impact potential to meet diverse consumer needs
Nitches ensures product quality through adherence to FDA 21 CFR 111, NSF, and ISO-90001 certifications. The company is in the final stages of discovery and formulation, with detailed product information to be revealed in the coming weeks.